Toril Tefre
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
-
- Carcinogens and Genotoxicity Assessment
Papers in
-
- DNA Repair Mechanisms 2
- Glycosylation and Glycoproteins Research 2
- PI3K/AKT/mTOR signaling in cancer 2
- Protein Kinase Regulation and GTPase Signaling 2
-
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Ann K. Daly (2 shared papers)Jeffrey R. Idle (2 shared papers)Anne‐Lise Børresen (2 shared papers)Ole A. Andreassen (1 shared paper)Vidar M. Steen (1 shared paper)Aage Haugen (5 shared papers)Vidar Skaug (4 shared papers)David Ryberg (4 shared papers)
- Journals
- Environmental Health Perspectives (2 papers)Reproductive Toxicology (1 paper)Radiation Oncology (1 paper)British Journal of Cancer (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (1 paper)
- Partner nations
- NorwayUnited StatesUnited Kingdom
In The Last Decade
Toril Tefre
11 papers receiving 536 citations
Peers
Comparison fields: 5 of 74
- Pharmacology 212
- Cancer Research 118
- Oncology 99
- Molecular Biology 228
- Health, Toxicology and Mutagenesis 37
Countries citing papers authored by Toril Tefre
This map shows the geographic impact of Toril Tefre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toril Tefre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toril Tefre more than expected).
Fields of papers citing papers by Toril Tefre
This network shows the impact of papers produced by Toril Tefre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toril Tefre. The network helps show where Toril Tefre may publish in the future.
Co-authors
The 25 scholars most cited alongside Toril Tefre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 213 | |
| 2 | 1991 | 143 | |
| 3 | 1990 | 40 | |
| 4 | 2007 | 38 | |
| 5 | 2011 | 32 | |
| 6 | 1994 | 31 | |
| 7 | 1987 | 29 | |
| 8 | 1990 | 14 | |
| 9 | 1990 | 8 | |
| 10 | 1992 | 6 | |
| 11 | 1992 | 1 |
About Toril Tefre
Toril Tefre is a scholar working on Molecular Biology, Pharmacology, Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Health, Toxicology and Mutagenesis, having authored 11 papers that have together received 555 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), DNA Repair Mechanisms (2 papers), Glycosylation and Glycoproteins Research (2 papers), Lung Cancer Treatments and Mutations (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Endoplasmic Reticulum Stress and Disease (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Pharmacology (212 citations), Cancer Research (118 citations), Oncology (99 citations), Molecular Biology (228 citations) and Health, Toxicology and Mutagenesis (37 citations). Toril Tefre has collaborated with scholars based in Norway, United States and United Kingdom. Frequent co-authors include Ann K. Daly, Jeffrey R. Idle, Anne‐Lise Børresen, Ole A. Andreassen, Vidar M. Steen, Aage Haugen, Vidar Skaug, David Ryberg, Daniel W. Nebert and Steinar Aamdal. Their work appears in journals such as Environmental Health Perspectives, Reproductive Toxicology, Radiation Oncology, British Journal of Cancer and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.